Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
暂无分享,去创建一个
Dennis P. Robinson | J. Cerhan | N. Camp | C. Vachon | N. Rothman | S. Chanock | H. Adami | A. Brooks-Wilson | J. Spinelli | C. Skibola | T. Shanafelt | S. Berndt | P. Brennan | S. de Sanjosé | S. Slager | P. Boffetta | M. Melbye | M. Liebow | P. Bracci | R. Severson | K. Curtin | J. Johnston | N. Kay | N. Caporaso | H. Hjalgrim | L. Morton | B. Glimelius | J. McKay | W. Cozen | P. Cocco | A. Norman | L. Conde | L. Goldin | J. Weinberg | Y. Benavente | A. Nieters | A. Monnereau | K. E. Smedby | C. Vajdic | T. Call | M. Glenn | J. Clavel | C. Hanson | D. Casabonne | J. Leis | G. Kleinstern | S. Chanock | K. G. Chaffee | M. Maynadie | Sonja I. Berndt | J. Mckay | P. Brennan | Neil E Kay | J. B. Weinberg | S. Slager | Nicola J. Camp | P. Cocco | James B. Johnston
[1] S. Gabriel,et al. Rare Germline Variants in ATM Are Associated with Chronic Lymphocytic Leukemia , 2017, Leukemia.
[2] Paolo Vineis,et al. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia , 2017, Nature Communications.
[3] G. Marti,et al. Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility. , 2016, Blood.
[4] S. Cummings,et al. Breast cancer risk prediction using a clinical risk model and polygenic risk score , 2016, Breast Cancer Research and Treatment.
[5] Paolo Vineis,et al. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia , 2016, Nature Communications.
[6] X. Hua,et al. Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data , 2016, bioRxiv.
[7] J. Cerhan,et al. Familial predisposition and genetic risk factors for lymphoma. , 2015, Blood.
[8] T. Sellers,et al. Prediction of individual genetic risk to prostate cancer using a polygenic score , 2015, The Prostate.
[9] J. Cerhan,et al. Risk of Non-hematologic Cancer in Individuals with High Count Monoclonal B-Cell Lymphocytosis (MBL) , 2015, Leukemia.
[10] Jane E. Carpenter,et al. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants , 2015, JNCI Journal of the National Cancer Institute.
[11] Paolo Vineis,et al. A genome-wide association study of marginal zone lymphoma shows association to the HLA region , 2015, Nature Communications.
[12] A. Pettitt,et al. Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk , 2014, Leukemia.
[13] Jian Gu,et al. Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region , 2022 .
[14] Paolo Vineis,et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma , 2014, Nature Genetics.
[15] D. Weisenburger,et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[16] J. Cerhan,et al. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[17] Aneela Majid,et al. A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia , 2013, Nature Genetics.
[18] Paolo Vineis,et al. Genome-wide Association Study Identifies Multiple Risk Loci for Chronic Lymphocytic Leukemia , 2013, Nature Genetics.
[19] J. Cerhan,et al. Mapping of the IRF8 Gene Identifies a 3′UTR Variant Associated with Risk of Chronic Lymphocytic Leukemia but not Other Common Non-Hodgkin Lymphoma Subtypes , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[20] S. de Sanjosé,et al. Common Infectious Agents and Monoclonal B-Cell Lymphocytosis: A Cross-Sectional Epidemiological Study among Healthy Adults , 2012, PloS one.
[21] Sebastian M. Armasu,et al. Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism , 2011, Journal of thrombosis and haemostasis : JTH.
[22] Celine M Vachon,et al. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. , 2011, Blood.
[23] R. Houlston,et al. Inherited genetic susceptibility to monoclonal B-cell lymphocytosis. , 2010, Blood.
[24] G. Marti,et al. Common occurrence of monoclonal B‐cell lymphocytosis among members of high‐risk CLL families , 2010, British journal of haematology.
[25] E. Campo,et al. Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk , 2010, Nature Genetics.
[26] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[27] Neil E Caporaso,et al. B-cell clones as early markers for chronic lymphocytic leukemia. , 2009, The New England journal of medicine.
[28] Marcos González,et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. , 2009, Blood.
[29] K. Stamatopoulos,et al. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. , 2009, Blood.
[30] M. Björkholm,et al. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin’s lymphomas among relatives of patients with chronic lymphocytic leukemia , 2009, Haematologica.
[31] Guy Pratt,et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia , 2008, Nature Genetics.
[32] B. Ponder,et al. Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.
[33] Michael Hallek,et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.
[34] Paolo Ghia,et al. Diagnostic criteria for monoclonal B‐cell lymphocytosis , 2005, British journal of haematology.
[35] R. Kerber,et al. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database , 2005, Cancer.
[36] G. Guida,et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. , 2004, Blood.
[37] Michael J. Green,et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. , 2002, Blood.
[38] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[39] M. Dyer,et al. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia. , 2016, Blood.
[40] J. Cerhan,et al. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls , 2013, Leukemia.
[41] Stanley Lemeshow,et al. Applied Logistic Regression, Second Edition , 1989 .